Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis.

× No keyword cloud information.

48 in total

1. Delayed short-course treatment with teriparatide (PTH(1-34)) improves femoral allograft healing by enhancing intramembranous bone formation at the graft-host junction.

Authors: Masahiko Takahata; Edward M Schwarz; Tony Chen; Regis J O'Keefe; Hani A Awad
Journal: J Bone Miner Res Date: 2012-01 Impact factor: 6.741

2. In vivo effects of two novel ALN-EP4a conjugate drugs on bone in the ovariectomized rat model for reversing postmenopausal bone loss.

Authors: S Hu; C C Liu; G Chen; T Willett; R N Young; M D Grynpas
Journal: Osteoporos Int Date: 2015-08-14 Impact factor: 4.507

Review 3. Breaking new ground to build bone.

Authors: Lauren A Kingsley; John M Chirgwin; Theresa A Guise
Journal: Proc Natl Acad Sci U S A Date: 2007-06-20 Impact factor: 11.205

4. Hypoparathyroidism: is it time for replacement therapy?

Authors: Mara J Horwitz; Andrew F Stewart
Journal: J Clin Endocrinol Metab Date: 2008-09 Impact factor: 5.958

5. Evaluation of the effect of teriparatide therapy on mandibular fracture healing in rats with medication-related osteonecrosis of the jaw.

Authors: Mohammad Zandi; Arash Dehghan; Payam Amini; Shideh Doulati; Leila Rezaeian
Journal: Clin Oral Investig Date: 2019-02-04 Impact factor: 3.573

6. Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment.

Authors: Donna M Sosnoski; Robert J Norgard; Cassidy D Grove; Shelby J Foster; Andrea M Mastro
Journal: Clin Exp Metastasis Date: 2015-03-08 Impact factor: 5.150

7. Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor.

Authors: Thomas Dean; Jean-Pierre Vilardaga; John T Potts; Thomas J Gardella
Journal: Mol Endocrinol Date: 2007-09-13

Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis.